FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philip Bejon

Research Profile

Chemicals & Drugs

Living Beings

Geographic Areas

Kenya

Disorders

Physiology

Immunologic Memory

Concepts & Ideas

Anatomy

T-Lymphocytes

Procedures

Co-author Network

Publications

TOP 3
Philip Bejon; Kalifa Bojang; Salim Abdulla; Selidji T Agnandji; Kwaku P Asante; John P A Lusingu; Ally Olotu; Nekoye N Otsyula; Seth Owusu-Agyei; Nahya Salim; Michael T White; Azra C Ghani
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.
Caroline Gikonyo; Dorcas Kamuya; Vicki Marsh; Bibi Mbete; Patricia Njuguna; Ally Olotu; Philip Bejon; Sassy Molyneux
Feedback of research findings for vaccine trials: experiences from two Malaria vaccine trials involving healthy children on the Kenyan Coast.
Ally Olotu; Norbert Peshu; Juliana Wambua; Ken O Awuondo; Greg Fegan; Amanda Leach; Didier Leboulleux; Marc Lievens; Kevin Marsh; Patricia Njuguna; George Nyangweso; Philip Bejon
Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philip Bejon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Philip Bejon; Kalifa Bojang; Salim Abdulla; Selidji T Agnandji; Kwaku P Asante; John P A Lusingu; Ally Olotu; Nekoye N Otsyula; Seth Owusu-Agyei; Nahya Salim; Michael T White; Azra C Ghani
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.
The Lancet infectious diseases 2013;13(4):319-27.
2013: Caroline Gikonyo; Dorcas Kamuya; Vicki Marsh; Bibi Mbete; Patricia Njuguna; Ally Olotu; Philip Bejon; Sassy Molyneux
Feedback of research findings for vaccine trials: experiences from two Malaria vaccine trials involving healthy children on the Kenyan Coast.
Developing world bioethics 2013;13(1):48-56.
2013: Ally Olotu; Norbert Peshu; Juliana Wambua; Ken O Awuondo; Greg Fegan; Amanda Leach; Didier Leboulleux; Marc Lievens; Kevin Marsh; Patricia Njuguna; George Nyangweso; Philip Bejon
Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
The New England journal of medicine 2013;368(12):1111-20.
2013: Joseph Illingworth; Kevin Marsh; Jedidah Mwacharo; Philip Bejon; Noah S Butler; Peter D Crompton; Susan K Pierce; Sophie Roetynck; Francis M Ndungu
Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(3):1038-47.
2013: Michael T White; Philip Bejon; James T Griffin; Kent E Kester; Christian F Ockenhouse; Ally Olotu; Eleanor M Riley; Azra C Ghani
The Relationship between RTS,S Vaccine-Induced Antibodies, CD4(+) T Cell Responses and Protection against Plasmodium falciparum Infection.
PloS one 2013;8(4):e61395.
2013: George M Warimwe; Philip Bejon; Helen A Fletcher; Adrian V S Hill; Gathoni Kamuyu; Linda M Murungi; Vivek Naranbhai; George M Nyangweso; F H A Osier; Juliana Wambua; Kevin Marsh
The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children.
PloS one 2013;8(2):e57320.
2012: Francis M Ndungu; Mary Nyonda; Ally Olotu; Lazarus K Mramba; Jedidah Mwacharo; Jordan Apfeld; Philip Bejon; Greg Fegan; Kevin Marsh
Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(21):8247-52.
2012: Amir Horowitz; Elizabeth King; Amanda Leach; John P A Lusingu; Philippe Moris; Philip Bejon; Joe Cohen; Patrick H Corran; Denise Dekker; Chris Drakeley; Julius Hafalla; Johan Vekemans; Tonya Villafana; Lorenz Von Seidlein; Eleanor M Riley
Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(10):5054-62.
2012: Frances Ibison; Domtila Kimani; Kevin Marsh; Daniel M Muema; Jedidah Mwacharo; Eric Ohuma; Ally Olotu; Philip Bejon; Francis M Ndungu
Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.
PloS one 2012;7(12):e52939.
2012: Francis M Ndungu; Ally Olotu; Johan Vekemans; Erik Jongert; Oscar Kai; Domtila Kimani; Philippe Moris; Jedidah Mwacharo; Philip Bejon
A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E.
PloS one 2012;7(12):e52870.
2012: Ally Olotu; Juliana Wambua; Chris Drakeley; Greg Fegan; Kevin Marsh; George Nyangweso; Edna Ogada; Philip Bejon
Estimating individual exposure to malaria using local prevalence of malaria infection in the field.
PloS one 2012;7(3):e32929.
2012: Janet T Midega; Joseph M Mwangangi; George Nyangweso; Joseph G Nzovu; Ally Olotu; David L Smith; Juliana Wambua; George K Christophides; Kevin Marsh; Charles M Mbogo; Philip Bejon
Wind direction and proximity to larval sites determines malaria risk in Kilifi District in Kenya.
Nature communications 2012;3():674.
2011: H C Hughes; R Newnham; N Athanasou; B L Atkins; Philip Bejon; I C J W Bowler
Microbiological diagnosis of prosthetic joint infections: a prospective evaluation of four bacterial culture media in the routine laboratory.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2011;17(10):1528-30.
2011: Daniel P Webster; B C Young; B Batchelor; Philip Bejon; D Collyer; B D Cookson; D M Livermore; S Maharjan; R Morton; J F Turton; I C J W Bowler
Impact of a clonal outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in the development and evolution of bloodstream infections by K. pneumoniae and Escherichia coli: an 11 year experience in Oxfordshire, UK.
The Journal of antimicrobial chemotherapy 2011;66(9):2126-35.
2011: Philip Bejon; Jackie Cook; Elke Bergmann-Leitner; Ally Olotu; John P A Lusingu; Jedidah Mwacharo; Johan Vekemans; Patricia Njuguna; Amanda Leach; Marc Lievens; Sheetij Dutta; Lorenz Von Seidlein; Barbara Savarese; Tonya Villafana; Martha M Lemnge; Joe Cohen; Kevin Marsh; Patrick H Corran; Evelina Angov; Eleanor M Riley; Chris Drakeley
Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
The Journal of infectious diseases 2011;204(1):9-18.
2011: Philip Bejon; Bridget L Atkins; Ivor Byren; Roger Gundle; Peter McLardy-Smith; Matthew Scarborough; Andrew Woodhouse; Anthony R Berendt
Serial measurement of the C-reactive protein is a poor predictor of treatment outcome in prosthetic joint infection.
The Journal of antimicrobial chemotherapy 2011;66(7):1590-3.
2011: Symon M Kariuki; Michelle Ikumi; John Ojal; Manish Sadarangani; Richard Idro; Ally Olotu; Philip Bejon; James A Berkley; Kevin Marsh; Charles R J C Newton
Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast.
Brain : a journal of neurology 2011;134(Pt 5):1519-28.
2011: Ally Olotu; John P A Lusingu; Amanda Leach; Marc Lievens; Johan Vekemans; Salum Msham; Trudie Lang; Jayne Gould; Marie-Claude Dubois; Erik Jongert; Preeti Vansadia; Terrell Carter; Patricia Njuguna; Ken O Awuondo; Anangisye Malabeja; Omar Abdul; Samwel Gesase; Neema Mturi; Chris Drakeley; Barbara Savarese; Tonya Villafana; Didier Lapierre; W Ripley Ballou; Joe Cohen; Martha M Lemnge; Norbert Peshu; Kevin Marsh; Eleanor M Riley; Lorenz Von Seidlein; Philip Bejon
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
The Lancet infectious diseases 2011;11(2):102-9.
2011: Ally Olotu; Barbara Savarese; Johan Vekemans; Tonya Villafana; Joe Cohen; Michel Janssens; Erik Jongert; Oscar Kai; Domtila Kimani; Amanda Leach; Marc Lievens; Kevin Marsh; Philippe Moris; Jedidah Mwacharo; Philip Bejon
Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
PloS one 2011;6(10):e25786.
2011: Marc Lievens; Bruno Mmbando; Ali Mohamed; John Williamson; John J Aponte; Philip Bejon; Amanda Leach
Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.
Malaria journal 2011;10():222.
2011: Philip Bejon; Peter C Bull; Gerald Cham; Chris J Drakeley; Thomas Lavstsen; Marc Lievens; John P A Lusingu; Kevin Marsh; Ally Olotu; Barbara Savarese; Louise Turner; Johan Vekemans; Lorenz Von Seidlein; Thor G Theander
Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites.
PloS one 2011;6(6):e21711.
2011: Anne Liljander; Philip Bejon; Jedidah Mwacharo; Oscar Kai; Edna Ogada; Norbert Peshu; Kevin Marsh; Anna Färnert
Clearance of asymptomatic P. falciparum Infections Interacts with the number of clones to predict the risk of subsequent malaria in Kenyan children.
PloS one 2011;6(2):e16940.
2010: Philip Bejon; Thomas N Williams; Anne Liljander; Abdisalan M Noor; Juliana Wambua; Edna Ogada; Ally Olotu; F H A Osier; Simon I Hay; Anna Färnert; Kevin Marsh
Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya.
PLoS medicine 2010;7(7):e1000304.
2010: Ally Ibrahim Olotu; Greg Fegan; Philip Bejon
Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
The Journal of infectious diseases 2010;201(6):970-1.
2010: Ally Olotu; Greg Fegan; Thomas N Williams; Philip Sasi; Edna Ogada; Evasius Bauni; Juliana Wambua; Kevin Marsh; Steffen Borrmann; Philip Bejon
Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural Kenya.
PloS one 2010;5(12):e15569.
2009: Stephen Todryk; Michael Walther; Philip Bejon; Claire L Hutchings; Fiona M Thompson; Britta C Urban; David W Porter; Adrian V S Hill
Multiple functions of human T cells generated by experimental malaria challenge.
European journal of immunology 2009;39(11):3042-51.
2009: Stephen Todryk; Philip Bejon
Malaria vaccine development: lessons from the field.
European journal of immunology 2009;39(8):2007-10.
2009: James A Berkley; Philip Bejon; Tabitha Mwangi; Samson Gwer; Kathryn Maitland; Thomas N Williams; Shebe Mohammed; Faith Osier; Samson Kinyanjui; Greg Fegan; Brett S Lowe; Mike English; Norbert Peshu; Kevin Marsh; Charles Newton
HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(3):336-43.
2009: Philip Bejon; Salim Abdulla; John Lusingu; Ally Olotu; Amanda Leach; Marc Lievens; Marcel Tanner; Lorenz Von Seidlein
Response to "Poor control vaccines in two randomised trials of malaria vaccine?".
Vaccine 2009;27(35):4745-6.
2009: M Dudareva; Laura Andrews; Sarah Gilbert; Philip Bejon; Kevin Marsh; J Mwacharo; O Kai; A Nicosia; A V S Hill
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.
Vaccine 2009;27(27):3501-4.
2009: Timothy M Walker; I C J W Bowler; Philip Bejon
Risk factors for recurrence after Staphylococcus aureus bacteraemia. A retrospective matched case-control study.
The Journal of infection 2009;58(6):411-6.
2009: Philip Bejon; George Warimwe; Claire L Mackintosh; Margaret J Mackinnon; Sam M Kinyanjui; Jennifer N Musyoki; Peter C Bull; Kevin Marsh
Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure.
Infection and immunity 2009;77(5):1917-23.
2009: Jedidah Mwacharo; Susanna Dunachie; Oscar Kai; Adrian V S Hill; Philip Bejon; Helen A Fletcher
Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.
PloS one 2009;4(12):e8434.
2009: Philip Bejon; Edna Ogada; Norbert Peshu; Kevin Marsh
Interactions between age and ITN use determine the risk of febrile malaria in children.
PloS one 2009;4(12):e8321.
2009: Samson Kinyanjui; Philip Bejon; F H A Osier; Peter C Bull; Kevin Marsh
What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.
Malaria journal 2009;8():242.
2008: Philip Bejon; Shebe Mohammed; Isaiah Mwangi; Sarah H Atkinson; Faith Osier; Norbert Peshu; Charles Newton; Kathryn Maitland; James A Berkley
Fraction of all hospital admissions and deaths attributable to malnutrition among children in rural Kenya.
The American journal of clinical nutrition 2008;88(6):1626-31.
2008: Wendy P O'Meara; Philip Bejon; Tabitha W Mwangi; Emelda Okiro; Norbert Peshu; Robert W Snow; Charles Newton; Kevin Marsh
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya.
Lancet 2008;372(9649):1555-62.
2008: Caroline Gikonyo; Philip Bejon; Vicki Marsh; Sassy Molyneux
Taking social relationships seriously: lessons learned from the informed consent practices of a vaccine trial on the Kenyan Coast.
Social science & medicine (1982) 2008;67(5):708-20.
2008: Frances Sanderson; Laura Andrews; Alexander D Douglas; Angela Hunt-Cooke; Philip Bejon; Adrian V S Hill
Blood-stage challenge for malaria vaccine efficacy trials: a pilot study with discussion of safety and potential value.
The American journal of tropical medicine and hygiene 2008;78(6):878-83.
2008: George W Agak; Philip Bejon; Greg Fegan; Nimmo Gicheru; Viviane Villard; Andrey V Kajava; Kevin Marsh; Giampietro Corradin
Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya.
Vaccine 2008;26(16):1963-71.
2008: Stephen Todryk; Philip Bejon; Tabitha Mwangi; Magdalena Plebanski; Britta Urban; Kevin Marsh; Adrian V S Hill; Katie L Flanagan
Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.
PloS one 2008;3(4):e2027.
2008: Philip Bejon; Tabitha W Mwangi; Brett Lowe; Norbert Peshu; Adrian V S Hill; Kevin Marsh
Helminth infection and eosinophilia and the risk of Plasmodium falciparum malaria in 1- to 6-year-old children in a malaria endemic area.
PLoS neglected tropical diseases 2008;2(1):e164.
2007: Philip Bejon; Tabitha W Mwangi; Brett Lowe; Norbert Peshu; Adrian V S Hill; Kevin Marsh
Clearing asymptomatic parasitaemia increases the specificity of the definition of mild febrile malaria.
Vaccine 2007;25(48):8198-202.
2007: Philip Bejon; Jedidah Mwacharo; Oscar Kai; Stephen Todryk; Sheila Keating; Brett Lowe; Trudie Lang; Tabitha W Mwangi; Sarah Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill
The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(6):4193-201.
2007: Philip Bejon; James A Berkley; Tabitha W Mwangi; Edna Ogada; Isaiah Mwangi; Kathryn Maitland; Thomas Williams; J Anthony G Scott; Mike English; Brett S Lowe; Norbert Peshu; Charles Newton; Kevin Marsh
Defining childhood severe falciparum malaria for intervention studies.
PLoS medicine 2007;4(8):e251.
2007: Sassy Molyneux; Caroline Gikonyo; Vicki Marsh; Philip Bejon
Incorporating a quiz into informed consent processes: qualitative study of participants' reactions.
Malaria journal 2007;6():145.
2007: Philip Bejon; Edna Ogada; Tabitha W Mwangi; Paul Milligan; Trudie Lang; Greg Fegan; Sarah Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill
Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.
PloS one 2007;2(8):e707.
2006: Philip Bejon; Sheila Keating; Jedidah Mwacharo; Oscar Kai; Susanna Dunachie; Michael Walther; Tamara Berthoud; Trudie Lang; Judy Epstein; Daniel J Carucci; Philippe Moris; Joe Cohen; Sarah Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill
Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naïve and malaria-exposed individuals.
Infection and immunity 2006;74(11):6331-8.
2006: Michael Walther; John Woodruff; Fanny Edele; David Jeffries; Jon Eric Tongren; Elizabeth King; Laura Andrews; Philip Bejon; Sarah Gilbert; J Brian de Souza; Robert Sinden; Adrian V S Hill; Eleanor M Riley
Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(8):5736-45.
2006: Susanna Dunachie; Michael Walther; Judith E Epstein; Sheila Keating; Tamara Berthoud; Laura Andrews; Rikke F Andersen; Philip Bejon; Nilu Goonetilleke; Ian Poulton; Daniel P Webster; Geoffrey Butcher; Kate Watkins; Robert E Sinden; G L Levine; Thomas L Richie; Joerg Schneider; D Kaslow; Sarah Gilbert; Daniel J Carucci; Adrian V S Hill
A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.
Infection and immunity 2006;74(10):5933-42.
2006: Philip Bejon; Oscar Kai; Jedidah Mwacharo; Sheila Keating; Trudie Lang; Sarah Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill
Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area.
European journal of immunology 2006;36(8):2264-72.
2006: Philip Bejon; Jedidah Mwacharo; Oscar Kai; Stephen Todryk; Sheila Keating; Trudie Lang; Sarah Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.
Vaccine 2006;24(22):4709-15.
2006: Philip Bejon; Norbert Peshu; Sarah Gilbert; Brett S Lowe; Catherine S Molyneux; John Forsdyke; Trudie Lang; Adrian V S Hill; Kevin Marsh
Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(8):1102-10.
2006: Susanna Dunachie; Michael Walther; Jenni M Vuola; Daniel P Webster; Sheila Keating; Tamara Berthoud; Laura Andrews; Philip Bejon; Ian Poulton; Geoffrey Butcher; Kate Watkins; Robert E Sinden; Amanda Leach; Philippe Moris; Nadia Tornieporth; Joerg Schneider; Filip Dubovsky; Eveline Tierney; Jack Williams; Donald Heppner; Sarah Gilbert; Joe Cohen; Adrian V S Hill
A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
Vaccine 2006;24(15):2850-9.
2006: Philip Bejon; Laura Andrews; Angela Hunt-Cooke; Frances Sanderson; Sarah Gilbert; Adrian V S Hill
Thick blood film examination for Plasmodium falciparum malaria has reduced sensitivity and underestimates parasite density.
Malaria journal 2006;5():104.
2006: Philip Bejon; Jedidah Mwacharo; Oscar Kai; Tabitha W Mwangi; Paul Milligan; Stephen Todryk; Sheila Keating; Trudie Lang; Brett Lowe; Caroline Gikonyo; Catherine S Molyneux; Greg Fegan; Sarah Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.
PLoS clinical trials 2006;1(6):e29.
2005: Sheila Keating; Philip Bejon; Tamara Berthoud; Jenni M Vuola; Stephen Todryk; Daniel P Webster; Susanna Dunachie; Vasee S Moorthy; Samuel J McConkey; Sarah Gilbert; Adrian V S Hill
Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(9):5675-80.
2005: Michael Walther; Jon Eric Tongren; Laura Andrews; Daniel Korbel; Elizabeth King; Helen Fletcher; Rikke F Andersen; Philip Bejon; Fiona Thompson; Susanna Dunachie; Fanny Edele; J Brian de Souza; Robert E Sinden; Sarah Gilbert; Eleanor M Riley; Adrian V S Hill
Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection.
Immunity 2005;23(3):287-96.
2005: Laura Andrews; Rikke F Andersen; Daniel Webster; Susanna Dunachie; R Michael Walther; Philip Bejon; Angela Hunt-Cooke; Gillian Bergson; Frances Sanderson; Adrian V S Hill; Sarah Gilbert
Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials.
The American journal of tropical medicine and hygiene 2005;73(1):191-8.
2005: Philip Bejon; Isaiah Mwangi; Caroline Ngetsa; Salim Mwarumba; James A Berkley; Brett S Lowe; Kathryn Maitland; Kevin Marsh; Mike English; J Anthony G Scott
Invasive Gram-negative bacilli are frequently resistant to standard antibiotics for children admitted to hospital in Kilifi, Kenya.
The Journal of antimicrobial chemotherapy 2005;56(1):232-5.
2005: Jeffrey R Dorfman; Philip Bejon; Francis M Ndungu; Jean Langhorne; Moses Kortok; Brett S Lowe; Tabitha W Mwangi; Thomas N Williams; Kevin Marsh
B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area.
The Journal of infectious diseases 2005;191(10):1623-30.
2005: Daniel P Webster; Susanna Dunachie; Jenni M Vuola; Tamara Berthoud; Sheila Keating; Stephen M Laidlaw; Samuel J McConkey; Ian Poulton; Laura Andrews; Rikke F Andersen; Philip Bejon; Geoffrey Butcher; Robert Sinden; Michael A Skinner; Sarah Gilbert; Adrian V S Hill
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(13):4836-41.
2005: Philip Bejon; Laura Andrews; Rikke F Andersen; Susanna Dunachie; Daniel Webster; Michael Walther; Sarah Gilbert; T E A Peto; Adrian V S Hill
Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites.
The Journal of infectious diseases 2005;191(4):619-26.
2003: Kathryn Maitland; Philip Bejon; Charles Newton
Malaria.
Current opinion in infectious diseases 2003;16(5):389-95.